11/19/2009
Canadian Orebodies Inc. (TSX VENTURE: CO)("Orebodies") is pleased to announce that it has expanded the previously announced work program on its newly acquired Lithium/Rare Metals properties (the "Properties"). Due to better than expected weather conditions Orebodies has been able to extend and expand the work programs which it previously announced in Orebodies Press Release dated November 9, 2009.
The expanded program will include mechanical stripping on the Falcon property, focusing on the West deposit, to better expose and trace the zone which will be followed up with systematic channel sampling. Also, a third crew has been mobilized to the Greenbush property to commence detailed geological mapping and sampling. Having this additional crew made available means that work is now able to commence on all 5 of the newly acquired Properties, which will allow for the collection of information that will enable Orebodies to continue with its exploration and evaluation of the Properties over the winter months.
In order to complete the purchase of 100% interest in the Properties (subject to a 2% NSR retained by the vendor, 50% of which can be purchased by Orebodies for $1,000,000), Orebodies is required to issue an aggregate amount of 1,600,000 common shares of Orebodies and issue 1,600,000 share purchase warrants, each warrant entitling the holder to acquire one common share of Orebodies at an exercise price of $0.15 per share for a period of two years from closing. More information regarding the Properties can be found in Orebodies Press Release dated October 22, 2009.
Closing of the transaction remains subject to the approval of the TSX Venture Exchange and the execution of a definitive purchase agreement.
Forward Looking Information:
Some of the statements and information contained herein may be forward-looking information which involves known and unknown risks and uncertainties, including statements respecting the proposed acquisition of the claim units pursuant to the purchase. Without limitation, statements regarding the potential purchase of the claims, statements regarding potential mineralization and resources, proposed exploration activities and future plans and objectives of Orebodies are forward looking statements that involve various degrees of risk. The following are important factors that could cause Orebodies actual results to differ materially from those expressed or implied by such forward looking statements: changes in the world wide price of mineral commodities, general market conditions, the uncertainty of access to capital. In particular, there can be no assurance that the definitive purchase agreement will be entered into, that TSX Venture Exchange approval of the purchase will be obtained, or that Orebodies will undertake any or all of the payments or issuances necessary to complete the purchase.
Contacts: Canadian Orebodies Inc. Gordon McKinnon President & CEO (705) 268-9000 www.canadianorebodies.com
SOURCE: Canadian Orebodies Inc.
http://www.canadianorebodies.com
Copyright 2009 Marketwire, Inc., All rights reserved.

Liked By
Spread the love. Be the first to like this post!
Recent CO News
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 03/03/2023 09:20:52 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/03/2023 07:39:34 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/03/2023 01:01:32 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 12/02/2022 09:07:25 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 10/31/2022 08:03:30 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 10/21/2022 09:15:41 PM
- Global Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman Islands • Business Wire • 09/26/2022 08:07:00 PM
- Global Cord Blood trading halted by NYSE for ‘regulatory concern’ • TipRanks • 09/23/2022 06:07:52 PM
- The Grand Court of the Cayman Islands Granted Blue Ocean’s Application to Appoint Joint Provisional Liquidators for Global Cord Blood Corporation • Business Wire • 09/23/2022 05:52:00 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 08/24/2022 01:02:32 PM
- Annual and Transition Report (foreign Private Issuer) (20-f) • Edgar (US Regulatory) • 08/16/2022 08:26:00 PM
- Global Cord Blood Corporation Files Annual Report on Form 20-F • PR Newswire (US) • 08/16/2022 08:16:00 PM
- Notification That Form 20-f Will Be Submitted Late (nt 20-f) • Edgar (US Regulatory) • 08/02/2022 12:01:19 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 07/06/2022 08:22:26 PM
- Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM • PR Newswire (US) • 07/06/2022 08:16:00 PM
- Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 • PR Newswire (US) • 07/05/2022 08:16:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 06/27/2022 12:02:30 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 06/22/2022 08:01:30 PM
- Global Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for IND • Dow Jones News • 06/17/2022 04:49:00 PM
- Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis • PR Newswire (US) • 06/16/2022 08:20:00 PM
- Shareholders Led by Blue Ocean Announce Successful Results of Extraordinary General Meeting of Global Cord Blood Corporation • Business Wire • 06/16/2022 08:05:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 06/16/2022 12:38:47 PM
- Global Cord Blood Corporation Announces Purported EGM Is Not Validly Convened • PR Newswire (US) • 06/16/2022 12:30:00 PM
- Shareholders of Global Cord Blood Corporation Are Reminded to Comply with the Rules of Conduct When Attending the Extraordinary General Meeting and Exercising Their Voting Rights • Business Wire • 06/15/2022 11:38:00 AM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 06/15/2022 10:41:02 AM
Glucose Health, Inc. Fiscal 2022 Annual Report • GLUC • Mar 23, 2023 3:23 PM
Nextech3D.ai Announces Its AI-Powered SaaS Platform Toggle3D Experiences A +963% Jump in Users in 60-Days Crossing Over 1000 Users • NTAR • Mar 23, 2023 7:07 AM
Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • TMC • Mar 22, 2023 1:44 PM
Fineqia Announces Partnership with Paris Blockchain Week to Accelerate Digital Asset Innovation • FNQQF • Mar 22, 2023 10:03 AM
E-Cite and ClearMarket Launch Nationwide EV Distribution Network Becoming the First All EV Dealership Opening in the Cerritos Auto Square, the World's Largest Automall • VAPR • Mar 22, 2023 9:41 AM
Electromedical Announces $1.36M Net Proceeds from Building Sale to Fund WellnessPro Infinity ™ Launch and Convertible Note Retirement. • EMED • Mar 22, 2023 7:04 AM